These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 33326653)
1. Functional and clinical implications of genetic structure in 1686 Italian exomes. Birolo G; Aneli S; Di Gaetano C; Cugliari G; Russo A; Allione A; Casalone E; Giorgio E; Paraboschi EM; Ardissino D; Duga S; Asselta R; Matullo G Hum Mutat; 2021 Mar; 42(3):272-289. PubMed ID: 33326653 [TBL] [Abstract][Full Text] [Related]
2. High-frequency actionable pathogenic exome variants in an average-risk cohort. Rego S; Dagan-Rosenfeld O; Zhou W; Sailani MR; Limcaoco P; Colbert E; Avina M; Wheeler J; Craig C; Salins D; Röst HL; Dunn J; McLaughlin T; Steinmetz LM; Bernstein JA; Snyder MP Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30487145 [TBL] [Abstract][Full Text] [Related]
3. Actionable secondary findings in the 73 ACMG-recommended genes in 1559 Thai exomes. Chetruengchai W; Shotelersuk V J Hum Genet; 2022 Mar; 67(3):137-142. PubMed ID: 34621001 [TBL] [Abstract][Full Text] [Related]
4. A data set of variants derived from 1455 clinical and research exomes is efficient in variant prioritization for early-onset monogenic disorders in Indians. Kausthubham N; Shukla A; Gupta N; Bhavani GS; Kulshrestha S; Das Bhowmik A; Moirangthem A; Bijarnia-Mahay S; Kabra M; Puri RD; Mandal K; Verma IC; Bielas SL; Phadke SR; Dalal A; Girisha KM Hum Mutat; 2021 Apr; 42(4):e15-e61. PubMed ID: 33502066 [TBL] [Abstract][Full Text] [Related]
5. The burden of pathogenic variants in clinically actionable genes in a founder population. Lynch MT; Maloney KA; Pollin TI; Streeten EA; Xu H; ; Shuldiner AR; Van Hout CV; Gonzaga-Jauregui C; Mitchell BD Am J Med Genet A; 2021 Nov; 185(11):3476-3484. PubMed ID: 34467620 [TBL] [Abstract][Full Text] [Related]
6. Impact of functional studies on exome sequence variant interpretation in early-onset cardiac conduction system diseases. Hayashi K; Teramoto R; Nomura A; Asano Y; Beerens M; Kurata Y; Kobayashi I; Fujino N; Furusho H; Sakata K; Onoue K; Chiang DY; Kiviniemi TO; Buys E; Sips P; Burch ML; Zhao Y; Kelly AE; Namura M; Kita Y; Tsuchiya T; Kaku B; Oe K; Takeda Y; Konno T; Inoue M; Fujita T; Kato T; Funada A; Tada H; Hodatsu A; Nakanishi C; Sakamoto Y; Tsuda T; Nagata Y; Tanaka Y; Okada H; Usuda K; Cui S; Saito Y; MacRae CA; Takashima S; Yamagishi M; Kawashiri MA; Takamura M Cardiovasc Res; 2020 Nov; 116(13):2116-2130. PubMed ID: 31977013 [TBL] [Abstract][Full Text] [Related]
8. Carrier frequency of autosomal recessive genetic conditions in diverse populations: Lessons learned from the genome aggregation database. Schmitz MJ; Aarabi M; Bashar A; Rajkovic A; Gregg AR; Yatsenko SA Clin Genet; 2022 Aug; 102(2):87-97. PubMed ID: 35532184 [TBL] [Abstract][Full Text] [Related]
9. Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomes. Jang MA; Lee SH; Kim N; Ki CS Genet Med; 2015 Dec; 17(12):1007-11. PubMed ID: 25856671 [TBL] [Abstract][Full Text] [Related]
10. Targeted whole exome sequencing and Drosophila modelling to unveil the molecular basis of primary ovarian insufficiency. Bestetti I; Barbieri C; Sironi A; Specchia V; Yatsenko SA; De Donno MD; Caslini C; Gentilini D; Crippa M; Larizza L; Marozzi A; Rajkovic A; Toniolo D; Bozzetti MP; Finelli P Hum Reprod; 2021 Oct; 36(11):2975-2991. PubMed ID: 34480478 [TBL] [Abstract][Full Text] [Related]
11. A Screening Approach to Identify Clinically Actionable Variants Causing Congenital Heart Disease in Exome Data. Szot JO; Cuny H; Blue GM; Humphreys DT; Ip E; Harrison K; Sholler GF; Giannoulatou E; Leo P; Duncan EL; Sparrow DB; Ho JWK; Graham RM; Pachter N; Chapman G; Winlaw DS; Dunwoodie SL Circ Genom Precis Med; 2018 Mar; 11(3):e001978. PubMed ID: 29555671 [TBL] [Abstract][Full Text] [Related]
12. Findings of a 1303 Korean whole-exome sequencing study. Kwak SH; Chae J; Choi S; Kim MJ; Choi M; Chae JH; Cho EH; Hwang TJ; Jang SS; Kim JI; Park KS; Bang YJ Exp Mol Med; 2017 Jul; 49(7):e356. PubMed ID: 28706299 [TBL] [Abstract][Full Text] [Related]
13. The rate of secondary genomic findings in the Saudi population. Aloraini T; Alsubaie L; Alasker S; Al Muitiri A; Alswaid A; Eyiad W; Al Mutairi F; Ababneh F; Alfadhel M; Alfares A Am J Med Genet A; 2022 Jan; 188(1):83-88. PubMed ID: 34515413 [TBL] [Abstract][Full Text] [Related]
14. Frequency and spectrum of actionable pathogenic secondary findings in Taiwanese exomes. Kuo CW; Hwu WL; Chien YH; Hsu C; Hung MZ; Lin IL; Lai F; Lee NC Mol Genet Genomic Med; 2020 Oct; 8(10):e1455. PubMed ID: 32794656 [TBL] [Abstract][Full Text] [Related]
15. The ACMG SF v3.0 gene list increases returnable variant detection by 22% when compared with v2.0 in the ClinSeq cohort. Johnston JJ; Brennan ML; Radenbaugh B; Yoo SJ; Hernandez SM; ; Lewis KL; Katz AE; Manolio TA; Biesecker LG Genet Med; 2022 Mar; 24(3):736-743. PubMed ID: 34906458 [TBL] [Abstract][Full Text] [Related]
16. Association of varicose veins with rare protein-truncating variants in PIEZO1 identified by exome sequencing of a large clinical population. Smelser DT; Haley JS; Ryer EJ; Elmore JR; Cook AM; Carey DJ J Vasc Surg Venous Lymphat Disord; 2022 Mar; 10(2):382-389.e2. PubMed ID: 34358671 [TBL] [Abstract][Full Text] [Related]
17. Good performance of the criteria of American College of Medical Genetics and Genomics/Association for Molecular Pathology in prediction of pathogenicity of genetic variants causing thoracic aortic aneurysms and dissections. Ponińska JK; Bilińska ZT; Truszkowska G; Michalak E; Podgórska A; Stępień-Wojno M; Chmielewski P; Lutyńska A; Płoski R J Transl Med; 2022 Jan; 20(1):42. PubMed ID: 35078481 [TBL] [Abstract][Full Text] [Related]